Next Article in Journal
Vaccine Response in the Immunocompromised Patient with Focus on Cellular Immunity
Next Article in Special Issue
Immunogenicity Following Two Doses of the BBIBP-CorV Vaccine and a Third Booster Dose with a Viral Vector and mRNA COVID-19 Vaccines against Delta and Omicron Variants in Prime Immunized Adults with Two Doses of the BBIBP-CorV Vaccine
Previous Article in Journal
B-Cell-Based Immunotherapy: A Promising New Alternative
Previous Article in Special Issue
Systemic Cancer Therapy Does Not Significantly Impact Early Vaccine-Elicited SARS-CoV-2 Immunity in Patients with Solid Tumors
 
 
Article

Article Versions Notes

Vaccines 2022, 10(6), 880; https://doi.org/10.3390/vaccines10060880
Action Date Notes Link
article xml file uploaded 31 May 2022 09:09 CEST Original file -
article xml uploaded. 31 May 2022 09:09 CEST Update https://www.mdpi.com/2076-393X/10/6/880/xml
article pdf uploaded. 31 May 2022 09:09 CEST Version of Record https://www.mdpi.com/2076-393X/10/6/880/pdf
article html file updated 31 May 2022 09:11 CEST Original file -
article html file updated 3 August 2022 02:47 CEST Update https://www.mdpi.com/2076-393X/10/6/880/html
Back to TopTop